Hepatitis Technologies
My Account
Cart
Home
Products
About Our Products
Research
Founders Story
FibroScan
Diet
FAQ
Medical Team
About Us
About Hepatitis Technologies
The Dream
Proven Management System
Contact Us
Research: Resveratrol
Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.
Tuesday, January 01, 2008 - Written by J Appl Toxicol. 2008 Jan;28(1):35-43.
- 0 comments
Click here to read more.
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
Tuesday, June 26, 2001 - Written by Cancer Lett. 2001 Jun 26;167(2):151-6.
- 0 comments
Click here to read more.
Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyph
Saturday, April 01, 2000 - Written by Hepatology. 2000 Apr;31(4):922-31.
- 0 comments
Click here to read more.
Terms
Policies and Procedures
Site Map
Dealer Inquires
Educational Seminars
Practitioner Locater
Compassionate Relief Program
Copyright 2012 Hepatitis Technologies